Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Ascorbic Acid × Clear all

NCT03175341 2018-06-27

Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms